| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $537.9M | +21.3% |
| Cost of Revenue | $129.9M | +25.1% |
| Gross Profit | $408.0M | +20.2% |
| R&D Expense | $151.7M | +31.1% |
| SG&A Expense | $99.8M | +34.3% |
| Operating Income | -$88.8M | -202.4% |
| Interest Expense | $6.0M | -56.9% |
| Pre-tax Income | -$89.0M | -127.6% |
| Income Tax | $1.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $240.2M | -20.0% |
| Accounts Receivable | $106.3M | +38.3% |
| Current Assets | $600.1M | -8.7% |
| Total Assets | $819.6M | +4.2% |
| Current Liabilities | $406.9M | -37.1% |
| Total Liabilities | $813.6M | +14.0% |
| Stockholders' Equity | $6.0M | -91.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.3M | -77.3% |
| Capital Expenditures | $3.5M | -2.2% |
| Investing Cash Flow | -$68.0M | +0.9% |
| Financing Cash Flow | -$1.6M | +53.2% |
| Free Cash Flow | $7.9M | -83.0% |
| +242.1% |
| Net Income | -$90.9M | -141.0% |
| EPS (Basic) | -$1.72 | -132.4% |
| EPS (Diluted) | -$1.72 | -132.4% |